These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 608855)

  • 21. Peritoneal blood flow and peritoneal transfer parameters during dialysis with administration of drugs.
    Grzegorzewska AE; Antoniewicz K
    Adv Perit Dial; 1995; 11():28-32. PubMed ID: 8534723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tidal peritoneal dialysis: kinetics and protein balance.
    Flanigan MJ; Lim VS; Pflederer TA
    Am J Kidney Dis; 1993 Nov; 22(5):700-7. PubMed ID: 8238016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dialysis delivery in children on nightly intermittent and tidal peritoneal dialysis.
    Edefonti A; Consalvo G; Picca M; Giani M; Damiani B; Ghio L; Galato R
    Pediatr Nephrol; 1995 Jun; 9(3):329-32. PubMed ID: 7632525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats.
    Połubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Chen C; Moberly JB; Martis L; Breborowicz A; Oreopoulos DG
    Kidney Int; 2000 Mar; 57(3):1182-9. PubMed ID: 10720971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amphotericin selectively increases peritoneal ultrafiltration.
    Maher JF; Hirszel P; Bennett RR; Chakrabarti E
    Am J Kidney Dis; 1984 Nov; 4(3):285-8. PubMed ID: 6496470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of histamine and its receptor antagonists on peritoneal permeability.
    Shostak A; Chakrabarti E; Hirszel P; Maher JF
    Kidney Int; 1988 Dec; 34(6):786-90. PubMed ID: 3210539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amphotericin B does not increase peritoneal fluid removal.
    Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B
    Adv Perit Dial; 1998; 14():3-10. PubMed ID: 10649681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peritoneal solvent drag reflection coefficients are within the physiological range.
    Leypoldt JK; Blindauer KM
    Blood Purif; 1994; 12(6):327-36. PubMed ID: 7865191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New directions in peritoneal dialysis concepts and applications.
    Nolph KD; Miller F; Rubin J; Popovich R
    Kidney Int Suppl; 1980 Sep; 10():S111-6. PubMed ID: 6934332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the capillary wall in restricting diffusion of macromolecules. A study of peritoneal clearance of dextrans.
    Hirszel P; Shea-Donohue T; Chakrabarti E; Montcalm E; Maher JF
    Nephron; 1988; 49(1):58-61. PubMed ID: 2454414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microvascular and clinical effects of altered peritoneal dialysis solutions.
    Miller FN; Nolph KD; Harris PD; Rubin J; Wiegman DL; Joshua IG; Twardowski ZJ; Ghods AJ
    Kidney Int; 1979 Jun; 15(6):630-9. PubMed ID: 37363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peritoneal kinetics in children undergoing continuous ambulatory/cycling peritoneal dialysis.
    von Lilien T; Salusky IB; Little RJ; Alliapolous JC; Leichter HE; Hall TL; Fine RN
    Am J Kidney Dis; 1987 Dec; 10(6):431-8. PubMed ID: 3120579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of increased dialysate volume on peritoneal surface area among peritoneal dialysis patients.
    Chagnac A; Herskovitz P; Ori Y; Weinstein T; Hirsh J; Katz M; Gafter U
    J Am Soc Nephrol; 2002 Oct; 13(10):2554-9. PubMed ID: 12239245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmentation of peritoneal mass transport by dopamine: comparison with norepinephrine and evaluation of pharmacologic mechanisms.
    Hirszel P; Lasrich M; Maher JF
    J Lab Clin Med; 1979 Nov; 94(5):747-54. PubMed ID: 501201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follow-up of peritoneal clearances in patients undergoing continuous ambulatory peritoneal dialysis.
    Rubin J; Nolph K; Arfania D; Brown P; Prowant B
    Kidney Int; 1979 Nov; 16(5):619-23. PubMed ID: 548605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies to improve clinical outcomes in peritoneal dialysis patients: delivered dose and membrane transport.
    Churchill DN
    Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S58-62. PubMed ID: 9892367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrafiltration and clearance studies in human isolated peritoneal vascular loops.
    Ronco C; Brendolan A; Crepaldi C; Conz P; Bragantini L; Milan M; La Greca G
    Blood Purif; 1994; 12(4-5):233-42. PubMed ID: 7865182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dioctyl sodium sulphosuccinate increases net ultrafiltration in peritoneal dialysis.
    Wang T; Qureshi AR; Heimbürger O; Waniewski J; Chen C; Bergström J; Lindholm B
    Nephrol Dial Transplant; 1997 Jun; 12(6):1218-22. PubMed ID: 9198054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD.
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1997 Jun; 51(6):1885-92. PubMed ID: 9186879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients.
    Huang WH; Hung CC; Yang CW; Huang JY
    Ther Apher Dial; 2012 Aug; 16(4):361-7. PubMed ID: 22817125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.